Ore Pharmaceuticals Inc
(NASDAQ:ORXE)|
0.61 -0.03 (-4.69%) Dec 01 - Close |
|
|
|
After-Hours 0.85 +0.24 (39.34%) Mon, 1 Dec 2008 3:58 PM
- Compare ORXE with:
- View: Line | Candlestick
Company Profile
Ore Pharmaceuticals Inc
610 Professional Drive
Gaithersburg, MD 20879
United States - Map
Phone: (240) 361-4400
Fax: (301) 987-1701
Website: www.orepharma.com
State of incorporation: Delaware
CEO: Charles L. Dimmler, III
Employees: 71
Sector: Healthcare
Industry Group: Drugs
Industry: Diagnostic Substances
Provider of genomics-based information products
A drug repositioning and development company which focused on discovery of new indications for drugs and drug candidates.
Recent news for ORXE
-
GENE LOGIC INC Files SEC form 8-K, Other Events
EDGAR Online - Nov 18 at 11:28 ET
-
EDGAR Online Financials - Nov 05 at 9:04 ET
-
GENE LOGIC INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Oct 31 at 2:16 ET
-
Business Wire - Oct 31 at 5:00 ET
-
GENE LOGIC INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Oct 02 at 4:01 ET
-
Ore Pharmaceuticals Begins Clinical Trial of GL1001
Business Wire - Oct 01 at 5:00 ET
-
EDGAR Online - Sep 23 at 5:04 ET
-
GENE LOGIC INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Aug 07 at 4:29 ET
-
GENE LOGIC INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
EDGAR Online - Aug 06 at 4:01 ET
-
ORE PHARMACEUTICALS INC. Financials
EDGAR Online Financials - Jul 01 at 9:06 ET